A first-in-human trial of intravesical BH011, a novel docetaxel formulation, in patients with high risk non-muscle invasive bladder cancer (HR-NMIBC) after BCG failure: Results from a phase 1 study.
Recognition of the need to restore degraded landscapes is accelerating at pace. The UN Decade on Ecosystem Restoration (the UN Decade) has triggered a global movement to rally individual action, ...
We supposedly live in an era of “evidence-based medicine,” in which medical decisions are guided by the published data. But that approach is now being criticized because the “best evidence” is often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results